Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

COV.V Relative to the S&P 500

COV.V Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Covalon Technologies Ltd. (TSXV:COV.V) seasonal charts above shows that a Buy Date of October 26 and a Sell Date of January 15 has resulted in a geometric average return of 8.91% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 23.59% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada.

To download COV.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: COV.V